论文部分内容阅读
那天,我收到一位网民的来信,说她母亲60多岁了,以前有乙肝,去年发现肝硬化。虽然经过检查,乙肝病毒复制指标呈阳性,但因为肝功能一直正常,所以犹豫是否要进行抗病毒治疗。我国的《慢性乙型肝炎防治指南》建议慢性乙型肝炎抗病毒治疗的适应症除了要看病毒复制指标外,还要看肝功能。一般应该在ALT升高到正常值上限两倍以上再开始治疗。但是,对于乙肝肝硬化患者则不一样了。我国的《慢性乙型肝炎防治指南》依据新的循证医学证据,适度放宽慢性乙肝肝硬化患者的抗
That day, I received a letter from an Internet user saying that her mother was over 60 years old. He used to have hepatitis B and found cirrhosis last year. Although after inspection, hepatitis B virus replication index was positive, but because of liver function has been normal, so hesitate to antiviral therapy. China’s “Guidelines for the Prevention and Treatment of Chronic Hepatitis B” suggested that the indications of antiviral treatment of chronic hepatitis B in addition to look at viral replication indicators, but also depends on liver function. The ALT should generally be raised to more than twice the upper limit of normal before beginning treatment. However, for patients with hepatitis B cirrhosis is not the same. China’s “Guidelines for the Prevention and Treatment of Chronic Hepatitis B” based on new evidence-based medicine, moderate relaxation of patients with chronic hepatitis B cirrhosis